Regulation of autoreactive antibodies

Current Opinion in Rheumatology

Volumn 19, Issue 5, 2007, Pages 421-426

  Yurasov, Sergey ^a,b   Nussenzweig, Michel C ^a,c  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Antibody; Autoimmunity; B cells

Indexed keywords

ANTIBODY;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BAGG ALBINO MOUSE; BONE MARROW; C57BL 6 MOUSE; CLONAL ANERGY; GENE CONTROL; GENE DELETION; HUMAN; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; REVIEW;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN CLASS SWITCHING; MICE; SELF TOLERANCE;

EID: 34548364099     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e328277ef3b     Document Type: Review

References (53)

1. Tonegawa S. Somatic generation of antibody diversity. Nature 1983; 302:575-581.
2. Meffre E, Casellas R, Nussenzweig MC. Antibody regulation of B cell development. Nat Immunol 2000; 1:379-385.
3. Wardemann H, Yurasov S, Schaefer A, et al. Predominant autoantibody production by early human B cell precursors. Science 2003; 301:1374-1377.
4. Nemazee D, Weigert M. Revising B cell receptors. J Exp Med 2000; 191:1813-1817.
5. Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol 2006; 6:728-740.
6. Pelanda R, Torres RM. Receptor editing for better or for worse. Curr Opin Immunol 2006; 18:184-190.
7. Gauld SB, Merrell KT, Cambier JC. Silencing of autoreactive B cells by anergy: a fresh perspective. Curr Opin Immunol 2006; 18:292-297.
8. Halverson R, Torres RM, Pelanda R. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat Immunol 2004; 5:645-650.
9. Casellas R, Zhang Q, Zheng NY, et al. Ig kappa allelic inclusion is a consequence of receptor editing. J Exp Med 2007; 204:153-160. This report describes receptor editing and deletion in mice heterozygous for human Cκ and mouse Cκ, using a combination of flow cytometry, single cell RT-PCR, confocal microscopy, and hybridoma analysis.
10. + memory B cell development. J Exp Med 2006; 203:393-400. This paper provides a detailed description, using a single-cell cloning approach, of IgM memory B-cell reactivity in healthy human volunteers.
11. + memory B cells. Immunity 2007; 26:205-213. This paper provides a detailed description, using a single-cell cloning approach, of IgM memory B-cell reactivity in healthy human volunteers.
12. Yurasov S, Wardemann H, Hammersen J, et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 2005; 201:703-711.
13. Samuels J, Ng YS, Coupillaud C, et al. Impaired early B cell tolerance in patients with rheumatoid arthritis. J Exp Med 2005; 201:1659-1667.
14. Gay D, Saunders T, Camper S, Weigert M. Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med 1993; 177:999-1008.
15. Radic MZ, Erikson J, Litwin S, Weigert M. B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med 1993; 177:1165-1173.
16. Zhang Z, Burrows PD, Cooper MD. The molecular basis and biological significance of VH replacement. Immunol Rev 2004; 197:231-242.
17. + B-cell lymphoma. Nature 1986; 322:843-846.
18. Reth M, Gehrmann P, Petrac E, Wiese P. A novel VH to VHDJH joining mechanism in heavy-chain-negative (null) pre-B cells results in heavy-chain production. Nature 1986; 322:840-842.
19. H rearrangement inserted into its physiological position in the IgH chain locus.
20. Sekiguchi DR, Eisenberg RA, Weigert M. Secondary heavy chain rearrangement: a mechanism for generating antidouble-stranded DNA B cells. J Exp Med 2003; 197:27-39.
21. Wilson PC, Wilson K, Liu YJ, et al. Receptor revision of immunoglobulin heavy chain variable region genes in normal human B lymphocytes. J Exp Med 2000; 191:1881-1894.
22. H gene replacement to the primary B cell repertoire. Immunity 2003; 19:21-31.
23. Prak EL, Trounstine M, Huszar D, Weigert M. Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance. J Exp Med 1994; 180:1805-1815.
24. Li Y, Li H, Ni D, Weigert M. Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern. J Exp Med 2002; 196:1543-1552.
25. + anti-DNA plasma cells. Nat Immunol 2005; 6:99-106.
26. Li H, Jiang Y, Prak EL, et al. Editors and editing of anti-DNA receptors. Immunity 2001; 15:947-957.
27. Witsch EJ, Cao H, Fukuyama H, Weigert M. Light chain editing generates polyreactive antibodies in chronic graft-versus-host reaction. J Exp Med 2006; 203:1761-1772. An analysis of incomplete editing and double light chain expression, and its relationship with antibody polyreactivity is presented.
28. Doyle CM, Han J, Weigert MG, Prak ET. Consequences of receptor editing at the lambda locus: multireactivity and light chain secretion. Proc Natl Acad Sci USA 2006; 103:11264-11269. This study provides further description of the consequences of Igλ locus receptor editing for Igλ expression and reactivity in Igk locus deficient mice.
29. Li Y, Li H, Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med 2002; 195:181-188.
30. Li Y, Louzoun Y, Weigert M. Editing anti-DNA B cells by Vlambdax. J Exp Med 2004; 199:337-346.
31. Zhang M, Carroll MC. Natural antibody mediated innate autoimmune response. Mol Immunol 2007; 44 (1-3):103-110.
32. Casellas R, Shih TA, Kleinewietfeld M, et al. Contribution of receptor editing to the antibody repertoire. Science 2001; 291:1541-1544.
33. Retter MW, Nemazee D. Receptor editing occurs frequently during normal B cell development. J Exp Med 1998; 188:1231-1238.
34. Rice JS, Newman J, Wang C, et al. Receptor editing in peripheral B cell tolerance. Proc Natl Acad Sci USA 2005; 102:1608-1613.
35. Liu S, Velez MG, Humann J, et al. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens. J Immunol 2005; 175:5067-5076.
36. Radic MZ, Weigert M. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 1994; 12:487-520.
37. Weller S, Reynaud CA, Weill JC. Vaccination against encapsulated bacteria in humans: paradoxes. Trends Immunol 2005; 26:85-89.
38. Carsetti R, Rosado MM, Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev 2004; 197:179-191.
39. Weller S, Braun MC, Tan BK, et al. Human blood IgM 'memory' B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004; 104:3647-3654.
40. Silverman GJ, Goodyear CS. Confounding B-cell defences: lessons from a staphylococcal superantigen. Nat Rev Immunol 2006; 6:465-475.
41. Lopes-Carvalho T, Foote J, Kearney JF. Marginal zone B cells in lymphocyte activation and regulation. Curr Opin Immunol 2005; 17:244-250.
42. McHeyzer-Williams LJ, Malherbe LP, McHeyzer-Williams MG. Checkpoints in memory B-cell evolution. Immunol Rev 2006; 211:255-268.
43. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol 1995; 7:812-818.
44. 1 chain can exert a unique signaling function that can partially replace that of the Igα/β heterodimer in B-cell development and may contribute to memory B-cell memory physiology.
45. 1 domain in B cells from transgenic mice with IgM receptors or chimeric IgMG receptors containing the IgG tail segment.
46. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med 2001; 345:340-350.
47. Melchers F, Rolink AR. B cell tolerance: how to make it and how to break it. Curr Top Microbiol Immunol 2006; 305:1-23.
48. Dorner T, Lipsky PE. Molecular basis of immunoglobulin variable region gene usage in systemic autoimmunity. Clin Exp Med 2005; 4:159-169.
49. Yurasov S, Tiller T, Tsuiji M, et al. Persistent expression of autoantibodies in SLE patients in remission. J Exp Med 2006; 203:2255-2261.
50. Cappione A, Anolik JH, Pugh-Bernard A, et al. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest 2005; 115:3205-3216.
51. Kaneko Y, Nimmerjahn F, Madaio MP, Ravetch JV. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med 2006; 203:789-797.
52. Mackay M, Stanevsky A, Wang T, et al. Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. J Exp Med 2006; 203: 2157-2164. This study describes FcγRIIb receptor expression on memory B cells from healthy volunteers and SLE patients, and its effects on BCR signaling.
53. Xiang Z, Cutler AJ, Brownlie RJ, et al. FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol 2007; 8:419-429. This is a comprehensive analysis of the effects of FcγRIIb expression and signaling on plasma cell homeostasis in mouse models.